Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

AddendumMetabolism Free access | 10.1172/JCI24335C1

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

Stuart P. Weisberg, Deborah Hunter, Reid Huber, Jacob Lemieux, Sarah Slaymaker, Kris Vaddi, Israel Charo, Rudolph L. Leibel, and Anthony W. Ferrante Jr.

Find articles by Weisberg, S. in: JCI | PubMed | Google Scholar

Find articles by Hunter, D. in: JCI | PubMed | Google Scholar

Find articles by Huber, R. in: JCI | PubMed | Google Scholar

Find articles by Lemieux, J. in: JCI | PubMed | Google Scholar

Find articles by Slaymaker, S. in: JCI | PubMed | Google Scholar

Find articles by Vaddi, K. in: JCI | PubMed | Google Scholar

Find articles by Charo, I. in: JCI | PubMed | Google Scholar

Find articles by Leibel, R. in: JCI | PubMed | Google Scholar

Find articles by Ferrante, A. in: JCI | PubMed | Google Scholar

Published May 1, 2006 - More info

Published in Volume 116, Issue 5 on May 1, 2006
J Clin Invest. 2006;116(5):1457–1457. https://doi.org/10.1172/JCI24335C1.
© 2006 The American Society for Clinical Investigation
Published May 1, 2006 - Version history
View PDF

Original citation: J. Clin. Invest.116:115-124 (2006). doi:10.1172/JCI24335

Citation for this addendum: J. Clin. Invest.116:1457 (2006). doi:10.1172/JCI24335C1

During revision of reference 11 (Brodmerkel, C.M., et al. 2005. Discovery and pharmacological characterization of a novel rodent active CCR2 antagonist, INCB3344. J. Immunol.175:5370-5378.), the structure of INCB3344 was omitted. The structure of INCB3344 follows:

Version history
  • Version 1 (May 1, 2006): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts